Onesource Specialty Pharma Quarterly Results for Trading Insights
ONESOURCE • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹11 Cr
QSept 2025
Onesource Specialty Pharma Quarterly Results Key Highlights
- Revenue of ₹379 Cr in Sept 2025 (-11.7% vs Mar 2025, +12.1% vs Sept 2024)
- Net Profit of ₹11 Cr in Sept 2025 (-88.9% vs Mar 2025, +126.2% vs Sept 2024)
- EBITDA of ₹110 Cr in Sept 2025 (-40.5% vs Mar 2025)
- Operating Margin of 28.0% in Sept 2025 (-15.0pp vs Mar 2025)
- Earnings Per Share of ₹0.92 in Sept 2025 (-89.3% vs Mar 2025)
Onesource Specialty Pharma Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 379 | 429 | 333 | 338 | 76 | -11.7% | 12.1% |
| Net Profit (₹ Cr) | 11 | 99 | 0 | -42 | -40 | - | - |
| EBITDA (₹ Cr) | 110 | 185 | 91 | 76 | 0 | - | - |
| EPS (₹) | 0.92 | 8.61 | -0.02 | -10.13 | -9.67 | - | - |
| Operating Margin (%) | 28.0% | 43.0% | 26.0% | 21.0% | -4.0% | - | - |
Onesource Specialty Pharma Share Price Trend Around Quarterly Results
Visualize Onesource Specialty Pharma's 1-year price movement across quarterly results — ideal for logging trades in Onesource Specialty Pharma share price
chart using Tickjournal. All values in ₹.
Related Pages for Onesource Specialty Pharma
Additional stock information and data for ONESOURCE
Revenue Trend (₹ Cr)
Sept 2024
338
Jun 2025
333
Mar 2025
429
Sept 2025
379
Net Profit Trend (₹ Cr)
Sept 2024
-42
Jun 2025
0
Mar 2025
99
Sept 2025
11
Operating Margin Trend (%)
Sept 2024
21.0%
Jun 2025
26.0%
Mar 2025
43.0%
Sept 2025
28.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Onesource Specialty Pharma quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1760.2 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3936.8 | 3,219 | 591 | +11.3% | - | 18.4% | 224.4 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1530.8 | 7,716 | 1,353 | +12.0% | - | 17.5% | 91.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1256.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 77.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores